Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomasHélène Lasolle, Gérald Raverot, Christine Cortet et al.|European Journal of Endocrinology|2017Cited by 142
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or PheochromocytomaAlexandre Buffet, Laurène Ben Aim, Sophie Leboulleux et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 124
Clinical reappraisal of <scp>SHORT</scp> syndrome with <i><scp>PIK3R1</scp></i> mutations: toward recommendation for molecular testing and managementChristel Thauvin-Robinet, M. Mathieu‐Dramard, Pierre Bitoun et al.|Clinical Genetics|2015Cited by 93
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndromeAntoine Tabarin, Jérôme Bertherat, Guillaume Assié et al.|Annales d Endocrinologie|2022Cited by 62
Use of dipeptidyl peptidase‐4 inhibitors and prognosis of <scp>COVID</scp> ‐19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the <scp>CORONADO</scp> studyRonan Roussel, Patrice Darmon, Matthieu Pichelin et al.|Diabetes Obesity and Metabolism|2021Cited by 36